David Sokol, considered by many to be the leading candidate to replace Warren Buffett as the chairman of Berkshire Hathaway (NYSE: BRK-A, BRK-B), has resigned. His stated reason was to build up a business to leave to his family. The real reason, it seems, is that Sokol took a major position in Lubrizol before Berkshire bought it at a substantial premium in a $9 billion deal. The bottom line is that these transactions always become known, and Sokol, who’s arguably one of the most capable executives in the world, got out in front of the bullet… Read More

David Sokol, considered by many to be the leading candidate to replace Warren Buffett as the chairman of Berkshire Hathaway (NYSE: BRK-A, BRK-B), has resigned. His stated reason was to build up a business to leave to his family. The real reason, it seems, is that Sokol took a major position in Lubrizol before Berkshire bought it at a substantial premium in a $9 billion deal. The bottom line is that these transactions always become known, and Sokol, who’s arguably one of the most capable executives in the world, got out in front of the bullet and left before he had to. Warren Buffett and Berkshire Hathaway are more than one man’s name and that of a large company — they are a platinum-coated brand that implies the absolute highest ethical and business standards. Berkshire, despite its gargantuan, multi-billion dollar market cap, is still a handshake company. Buffett has the cash to make the world turn with a phone call, sure, but his cache is more than that. The world trusts him. He’s known for being a straight-shooter. Sokol’s actions, which Buffett thinks are legal to the letter of the law, would still… Read More

A private think tank with an all-but unlimited budget… A maverick genius with a history of world-rattling results… A secret Pentagon “skunk works” defense project… And a fuel technology that could not only reduce the nation’s dependence on foreign oil, but also reverse global warming. Read More

My dad worked all the time when I was a kid. But early on Saturday mornings, he’d wake me while it was still dark and take me to the office with him. And about once a month, we’d slip away to the farm where he grew up… Read More

As the editor of Fast-Track Millionaire, I’m a sucker for a smart, profitable company that’s able to use its ability to innovate, dominate and make money. That’s why I’ve taken an interest in Hospital Corporation of America (HCA), which is about to launch an initial public offering, or… Read More

I confess. I love a good IPO (initial public offering). As part of the research for my Fast-Track Millionaire newsletter, I pore over every prospectus filed each month to take a look at who… Read More

I’d bet you had a strong opinion about it, no matter your political leanings, no matter your tax bracket.   Put simply, it has been one of the most controversial pieces of lawmaking in a generation. And no matter what you think about it, there’s no arguing the new laws are groundbreaking.   That’s exactly the sort of opportunity I’m always looking for.   #-ad_banner-#Truth be told, it’s my suspicion that this legislation — referred to by many as “ObamaCare” — will be unraveled by the courts in coming years. That’s OK. I think… Read More

I’d bet you had a strong opinion about it, no matter your political leanings, no matter your tax bracket.   Put simply, it has been one of the most controversial pieces of lawmaking in a generation. And no matter what you think about it, there’s no arguing the new laws are groundbreaking.   That’s exactly the sort of opportunity I’m always looking for.   #-ad_banner-#Truth be told, it’s my suspicion that this legislation — referred to by many as “ObamaCare” — will be unraveled by the courts in coming years. That’s OK. I think one piece of President Obama’s legacy in health care is untouchable — his push for electronic medical records (EMR).   First funded through the massive $800 billion stimulus bill passed soon after Obama took office, the idea behind EMR is that huge cost-savings can be extracted by providing physicians with total access to patient records, allowing them to avoid duplicate medical tests, watch for drug interactions, avoid errors and increase levels of efficiency in the doctor’s office, specialty clinic and hospital.   We’ve all seen how this plays out — doctors and staff are constantly asking… Read More

When I recommended this stock nearly two years ago it was paying a 14.4% yield. In most cases, yields this high aren’t safe. But this company is different. In short, it borrows money at very low interest rates, invests… Read More

Not long ago, I took my Game-Changing Stocks readers on a journey to the non-descript offices of an obscure Department of Defense agency that funds research into areas most people never imagine.   Occasionally, this cadre of uber-geniuses comes up with a real winner. Take the Internet, for… Read More

In simpler times, Purdue Pharma might not have had these troubles. But these aren’t simple times. The company makes the popular and addictive painkiller OxyContin, and not surprisingly, it’s a target for thieves and high-tech counterfeiters, both of which can intrude at vulnerable points in the supply… Read More

It’s not your imagination… it is getting more expensive to fill up at the gas pump. We had a reprieve for several months. Following the crash in oil, gas plunged well below $2 a gallon. Now it’s knocking down the $3 mark. As a… Read More